Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,460 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
FYR Diagnostics, Inc.Biotechnology
Missoula, Montana · founded 2020 · Equity, Convertible, Preferred stock, and any common stock issuable upon its con · 2 investors · Brian Conway, Michael Goguen
Moonlight Therapeutics Inc.Biotechnology
Marietta, Georgia · Equity · 30 investors · Harold Shlevin, Samirkumar Patel
NEUROONE MEDICAL TECHNOLOGIES CorpBiotechnology
Eden Prairie, Minnesota · Options, Convertible · 20 investors · Jeffrey Mathiesen, Ronald McClurg
Odyssey Therapeutics, Inc.Biotechnology
Boston, Massachusetts · founded 2021 · Equity · 43 investors · Timothy Walbert, Charles Baum
GelSana Therapeutics, Inc.Biotechnology
Aurora, Colorado · founded 2020 · Equity · 17 investors · Diana Verrilli, Melissa Krebs
Acenxion Biosytems, Inc.Biotechnology
Lawrence, Kansas · founded 2020 · Equity · 5 investors · Howard Goldstein, Brian Struchtemeyer
Exa Biosciences, Inc.Biotechnology
Boston, Massachusetts · founded 2023 · Equity · 1 investors · Xun Chen
Impact Proteomics, LLCBiotechnology
Pittsburgh, Pennsylvania · Options · 1 investors · Jonathan Minden, Jeffrey Whitmore
Noetik Inc.Biotechnology
South San Francisco, California · founded 2022 · Equity · 20 investors · James Hardiman, Jacob Rinaldi
Convergent Therapeutics, Inc.Biotechnology
Cambridge, Massachusetts · founded 2020 · Equity · 1 investors · Eric Sullivan, Jake Simson
Linus Biotechnology Inc.Biotechnology
North Brunswick, New Jersey · founded 2020 · Equity · 4 investors · Rafi Syed, Amol Deshpande
bioAffinity Technologies, Inc.Biotechnology
San Anonio, Texas · Equity, Options, Convertible · 3 investors · Vivienne Rebel, Gary Rubin
Sapere Bio, Inc.Biotechnology
Durham, North Carolina · Simple Agreement for Future Equity · 1 investors · Natalia Mitin
bioAffinity Technologies, Inc.Biotechnology
San Anonio, Texas · Equity, Options, Convertible · 3 investors · Gary Rubin, Maria Zannes
TearSolutions, Inc.Biotechnology
Charlottesville, Virginia · Simple Agreements for Future Equity (SAFEs) · 10 investors · Louis Alpern, James Ramey
KALM Therapeutics, Inc.Biotechnology
Huntsville, Alabama · founded 2024 · Equity · 14 investors · Chris Seibert, Anuj Singhal
Noveome Biotherapeutics, Inc.Biotechnology
Pittsburgh, Pennsylvania · Equity · 66 investors · Robert Langer, Michael Kaufman
Switchback Systems, Inc.Biotechnology
Santa Cruz, California · Equity · 8 investors · Craig Asher, Mary Noe
TracerDX, Inc.Biotechnology
New York, New York · founded 2021 · Equity · 18 investors · Mark Kaganovich
Flow Pharma, Inc.Biotechnology
Warrensville Heights, Ohio · Equity · 3 investors · Pamela Steele, Anthony Tufaro
SurgiBox Inc.Biotechnology
Cambridge, Massachusetts · Equity, Debt, Options, Convertible, Simple Agreements for Future Equity · 22 investors · Kelly Laurel, Atif Rakin
Kate Therapeutics Inc.Biotechnology
San Diego, California · founded 2020 · Equity · 5 investors · Kevin Forrest, Ph.D., Clare Ozawa, Ph.D.
Kate Therapeutics Inc.Biotechnology
San Diego, California · founded 2020 · Equity · 8 investors · Clare Ozawa, Ph.D., Kevin Forrest, Ph.D.
Kate Therapeutics Inc.Biotechnology
San Diego, California · founded 2020 · Equity · 1 investors · Clare Ozawa, Ph.D., Kevin Forrest, Ph.D.
Ambrosia Biosciences Inc.Biotechnology
Boulder, Colorado · founded 2024 · Equity · 6 investors · Kyle Lefkoff, John Orwin
BioDynamik, Inc.Biotechnology
Lake Forest, California · founded 2023 · Options · 1 investors · Shanbao Cheng, Johnny Chen
SPINEOLOGY INCBiotechnology
St. Paul, Minnesota · Equity · 33 investors · Greg Madden, Jamison Young
Harvard Apparatus Regenerative Technology, Inc.Biotechnology
Holliston, Massachusetts · Equity · 4 investors · William Fodor, Ting Li
Ensho Therapeutics, Inc.Biotechnology
Morris Plains, New York · founded 2024 · Options, Convertible, simple agreement for future equity. · 2 investors · Emily Weng, Bittoo Kanwar
VEDANTA BIOSCIENCES, INC.Biotechnology
Cambridge, Massachusetts · Debt, Options · 25 investors · John LaMattina, Charles Sherwood